Ubichem Research, which has locations in Eastleigh, UK and Budapest, Hungary, has successfully completed its first regulatory audit and is now approved by OGYI (Hungarian National Institute for Pharmacy) for the commercial supply of cGMP Active Pharmaceutical Ingredients (APIs). Reciprocal agreements mean that this approval is effective throughout the EU. Roger McDonald, director of Ubichem Research, commented, “This is a fantastic achievement, a real testament to the skill of our dedicated...